PATENT CLAIM ANALYSIS

Application Number: 15895883
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-02
Patent Classification: ["514", "639000"]

Abstract:
A method of modulating ribonucleotide reductase activity in a neoplastic cell includes administering to the cell an amount of a ribonucleotide reductase allosteric modulator (RRAmod), the amount being effective to inhibit neoplastic cell growth.

Claim (Index 4):
The method of  claim 1 , wherein modulating ribonucleotide reductase activity comprises modulating ribonucleotide reductase mediated catalyzation of ribonucleotides to deoxy ribonucleotides in the neoplastic cell, thereby unbalancing the nucleotide pool of DNA precursor molecules required for de novo DNA synthesis.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 88.0
- Lexical Diversity: 1.35714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14387151', '13840549', '14029066', '13879101', '11223433']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7715378698879277
- 35 USC 102 Novelty (BERT): 0.5769406905193359
- Combined Prediction Score: 0.7520781519510686
- Mean Citation Score: 276.552862
- Max Citation Score: 472.33466
- Similarity Product: 408.7781298044908

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test